Anabolic Agents for Systemic Use

DrugDrug NameDrug Indication
DB00621OxandroloneUse to promote weight gain after weight loss following extensive surgery.
DB01493EthylestrenolNot Available
DB06412OxymetholoneIndicated in the treatment of anemias caused by deficient red cell production. Acquired aplastic anemia, congenital aplastic anemia, myelofibrosis and the hypoplastic anemias due to the administration of myelotoxic drugs often respond. Oxymetholone should not replace other supportive measures such as transfusion, correction of iron, folic acid, vitamin B12 or pyridoxine deficiency, antibacterial therapy and the appropriate use of corticosteroids.
DB06718StanozololStanozolol is a synthetic anabolic steroid with therapeutic uses in treating C1-inhibitor deficient hereditary angioedema. C1-inhibitor is a protease that inhibits the complement system (part of the innate immune system), a biochemical chain of reactions which assists the body in removing pathogens from the body. Stanozolol may help control attacks of hereditary angioedema. Stanozolol can be administered orally or intramuscularly.
DB12787NorethandroloneNot Available
DB13169NandroloneNot Available
DB13185Oxabolone cipionateUsed as a performance enhancing drug illicitly in athletes.
DB13484QuinboloneNot Available
DB13586MetandienoneNot Available
DB13710MetenoloneNot Available
DB01708PrasteroneDHEA is taken as a supplement for a variety of unsubstantiated indications. The following indications have shown promise and are backed up by some scientific evidence: schizophrenia (DHEA may be more effective in women than men); improving the appearance of older people’s skin (taking DHEA by mouth seems to increase skin thickness and moisture, and decrease facial “age spots” in elderly men and women); improving ability to achieve an erection in men with sexual dysfunction. Additionally, DHEA has shown promise in improving symptoms of lupus (SLE). Taking DHEA by mouth along with conventional treatment may help reduce the number of times symptoms flare up and may allow a reduction in the dose of prescription drugs needed. DHEA may also help SLE symptoms such as muscle ache and mouth ulcers. DHEA also seems to strengthen bones in SLE patients being treated with high-dose steroids (corticosteroids). DHEA also shows promise in the treatment of osteoporosis. Taking DHEA by mouth daily seems to improve bone mineral density (BMD) in older women and men with osteoporosis or osteopenia (pre-osteoporosis). DHEA may also increase BMD in young women with the eating disorder called anorexia nervosa. DHEA is often prescribed in India for the induction of ovulation to improve chances of pregnancy.
DB02901StanoloneNot Available
DrugDrug NameTargetType
DB00621OxandroloneAndrogen receptortarget
DB00621OxandroloneCytochrome P450 2C9enzyme
DB06412OxymetholoneAndrogen receptortarget
DB06412OxymetholoneSerum albumincarrier
DB06412OxymetholoneSex hormone-binding globulincarrier
DB06412OxymetholoneNatriuretic peptides Btarget
DB06412OxymetholoneAmine oxidase [flavin-containing] Aenzyme
DB06412OxymetholoneCytochrome P450 2D6enzyme
DB06412Oxymetholone3-oxo-5-alpha-steroid 4-dehydrogenase 1enzyme
DB06412OxymetholoneCytochrome P450 3A4enzyme
DB06412OxymetholoneCytochrome P450 3A5enzyme
DB06412OxymetholoneCytochrome P450 3A7enzyme
DB06412OxymetholoneCytochrome P450 3A43enzyme
DB06718StanozololStanozolol Binding Protein (STBP)target
DB06718StanozololLow-affinity glucocorticoid-binding protein (LAGS)target
DB01708PrasteroneSteroid Delta-isomerasetarget
DB01708PrasteroneBile salt sulfotransferasetarget
DB01708PrasteroneCholesterol oxidasetarget
DB01708PrasteroneEstradiol 17-beta-dehydrogenase 1target
DB01708PrasteroneSulfotransferase family cytosolic 2B member 1target
DB01708PrasteroneCytochrome P450 3A4enzyme
DB01708PrasteroneCytochrome P450 3A7enzyme
DB01708PrasteronePeroxisome proliferator-activated receptor alphatarget
DB01708PrasteroneEstrogen receptor alphatarget
DB01708PrasteroneSigma non-opioid intracellular receptor 1target
DB01708PrasteroneEstrogen receptor betatarget
DB01708PrasteroneNuclear receptor subfamily 1 group I member 2target
DB01708PrasteroneNuclear receptor subfamily 1 group I member 3target
DB01708PrasteroneGABA-A receptor (anion channel)target
DB01708PrasteroneNMDA receptortarget
DB01708PrasteroneAndrogen receptortarget
DB02901StanoloneSex hormone-binding globulincarrier
DB02901StanoloneAndrogen receptortarget
DB02901StanoloneEstradiol 17-beta-dehydrogenase 1target
DB02901StanoloneMultidrug resistance protein 1transporter
DB02901StanoloneCholesterol side-chain cleavage enzyme, mitochondrialenzyme
DB02901StanoloneSteroid 17-alpha-hydroxylase/17,20 lyaseenzyme
DB02901StanoloneCytochrome P450 19A1enzyme
DB02901StanoloneEstrogen receptor alphatarget
DB02901StanoloneMineralocorticoid receptortarget